Scarica l'app Stockscreener
6.135
0.50%
0.135
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$6.00
Aprire:
$6.12
Volume 24 ore:
13,949
Relative Volume:
0.71
Capitalizzazione di mercato:
$86.04M
Reddito:
$49.98M
Utile/perdita netta:
$-9.64M
Rapporto P/E:
-8.6408
EPS:
-0.71
Flusso di cassa netto:
$-4.86M
1 W Prestazione:
-7.80%
1M Prestazione:
-11.32%
6M Prestazione:
-7.23%
1 anno Prestazione:
+38.94%
Intervallo 1D:
$6.10
$6.25
Intervallo di 1 settimana:
$5.96
$6.57
Portata 52W:
$4.31
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Nome
Champions Oncology Inc
Settore
Industria
Telefono
410-369-0365
Indirizzo
855 N. WOLFE STREET, BALTIMORE, NJ
Confronta CSBR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
6.2401 | 84.11M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.72 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.67 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.78 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
900.00 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.93 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-12 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-11-18 | Iniziato | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Borsa (CSBR) Ultime notizie
Will Champions Oncology Inc. (2I3) stock beat value stocks2025 Stock Rankings & Expert Curated Trade Setups - Newser
Will Champions Oncology Inc. stock deliver consistent dividendsJuly 2025 Review & AI Enhanced Trade Execution Alerts - Newser
Will Champions Oncology Inc. (2I3) stock outperform benchmarksInflation Watch & Technical Pattern Based Buy Signals - Newser
Why (CSBR) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Champions Oncology Inc. (2I3) stock is a strong buy callWeekly Trade Recap & Breakout Confirmation Alerts - Newser
Will Champions Oncology Inc. stock benefit from infrastructure spending2025 Performance Recap & Step-by-Step Swing Trade Plans - Newser
Why pension funds invest in Champions Oncology Inc. (2I3) stock2025 Top Gainers & Verified Short-Term Trading Plans - Newser
Will Champions Oncology Inc. (2I3) stock deliver stable dividendsJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
What drives Champions Oncology Inc 2I3 stock priceMonthly Performance Summary & Achieve Triple Digit Returns - earlytimes.in
Patient-Derived Xenograft Model Market Size at USD 1.12 Billion in 2031, Forecasted to Grow at 13.4% CAGR Through 2031 | The Insight Partners (PR Newswire) - Aktiellt
Understanding Momentum Shifts in (CSBR) - news.stocktradersdaily.com
Will Champions Oncology Inc. stock outperform Nasdaq indexWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Quantitative breakdown of Champions Oncology Inc. recent move2025 Big Picture & Verified Entry Point Signals - newser.com
What dividend safety rating applies to Champions Oncology Inc. (2I3) stockDip Buying & Free Fast Entry Momentum Trade Alerts - newser.com
How Champions Oncology Inc. (2I3) stock behaves in tightening cycles2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Candlestick signals on Champions Oncology Inc. stock todayJuly 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Published on: 2025-11-19 21:53:34 - newser.com
How Champions Oncology Inc. (2I3) stock reacts to weak economy - newser.com
Why Champions Oncology Inc. is moving todayPortfolio Growth Summary & Real-Time Buy Signal Alerts - newser.com
Is Champions Oncology Inc. stock a buy in volatile marketsEarnings Recap Summary & Short-Term High Return Strategies - newser.com
Champions Oncology, Inc.Common Stock (NQ: CSBR - FinancialContent
Craig-Hallum Maintains Champions Oncology(CSBR.US) With Buy Rating, Announces Target Price $12 - 富途牛牛
Is Storage Technologies and Automation Limited Stock Set to Outperform Its Peers in YEARAutomated Trading Signals & Low Investment Wealth Tips - earlytimes.in
Champions Oncology Inc 2I3 Stock Analysis and ForecastCapital Gains Strategies & Investment Case Studies - earlytimes.in
Will Champions Oncology Inc. continue its uptrend2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Real time social sentiment graph for Champions Oncology Inc.2025 Bull vs Bear & Stock Timing and Entry Methods - newser.com
Champions Oncology Inc Azioni (CSBR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):